FORE US Bio Inc. — Form D

FORE US Bio Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2023-08-24. The offering totals $122.6M, of which $62.1M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2023-08-24
• Form: D
• Accession: 0001990659-23-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $122.6M
• Amount sold: $62.1M
• Remaining: $60.5M
• Investors: 20
• Date of first sale: 2023-08-09
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-490554

Issuer

• Name: FORE US Bio Inc.
• CIK: 0001990659
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2022
• Address: 3675 MARKET STREET SUITE 200, PHILADELPHIA, PA, 19104
• Phone: 267-641-7575

Officers, directors & promoters (23)

Other filings by this issuer (2)

More

• CIK 1990659 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search